News und Analysen

Home Depot (NYSE:HD), the world’s largest home improvement retailer, delivered its earnings results for the second quarter of fiscal 2025 on August 19, 2025. The headline news was GAAP revenue

XP(NASDAQ:XP) reported second quarter 2025 results on Aug. 18, 2025, delivering record net income of BRL1.321 billion, up 18% year over year, and a return on equity of 24.4%. Total client assets

Flexsteel Industries (NASDAQ:FLXS), a manufacturer of residential upholstered furniture, reported results for the quarter ended June 30, 2025, on Aug. 18, 2025. The headline news was a clear beat on

Blink Charging (NASDAQ:BLNK), a provider of electric vehicle (EV) charging equipment and services, reported its second quarter results on August 18, 2025. The headline news from the earnings release

Palo Alto Networks (NASDAQ:PANW), a leading global cybersecurity provider, reported its fiscal fourth quarter 2025 financial results on August 18, 2025. The company delivered results that were well

Duos Technologies Group (NASDAQ:DUOT), a provider of machine vision, artificial intelligence, and edge computing solutions, Duos Technologies Group announced its second-quarter 2025 earnings in

Applied Materials(NASDAQ:AMAT) reported third-quarter fiscal 2025 results on August 14, 2025, delivering record quarterly revenue of $7.3 billion (up 8% year over year), record non-GAAP earnings per

Eledon Pharmaceuticals (NASDAQ:ELDN), a biotechnology company focused on developing novel therapies for organ and cell transplantation as well as amyotrophic lateral sclerosis (ALS), issued its

Applied Materials (NASDAQ:AMAT), a leading supplier of materials engineering solutions for the semiconductor and display industries, reported its fiscal third-quarter results on Aug. 14, 2025. The

Strattec Security (NASDAQ:STRT), a leading designer and manufacturer of mechanical and electronic locks and access control products for the automotive industry, released its fourth quarter fiscal

RenovoRx (NASDAQ:RNXT), a medical technology company focused on targeted cancer therapy delivery, reported earnings on August 14, 2025. As sales of its RenovoCath device grew to $422,000 (GAAP)

SWK (NASDAQ:SWKH), a specialty finance company targeting the healthcare sector, announced its second quarter 2025 results on August 14, 2025. The most notable headline is that its non-GAAP adjusted

Phio Pharmaceuticals (NASDAQ:PHIO), a biotechnology company developing gene-silencing therapies for cancer, released its second quarter 2025 results on August 14, 2025. The quarter’s key news

Talphera (NASDAQ:TLPH), a specialty pharmaceutical company developing therapies for medically supervised hospital settings, reported its second quarter 2025 results on August 14, 2025. The company

Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14

Annexon (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing therapies for serious autoimmune and neurodegenerative diseases, released its second quarter 2025 financial results on

bioAffinity Technologies (NASDAQ:BIAF), a biotechnology company focused on noninvasive diagnostics and cancer therapeutics, reported results for Q2 2025 on August 14, 2025. The most significant news

Reading International (NASDAQ:RDI), an operator of cinemas and real estate properties across the United States, Australia, and New Zealand, reported its second quarter fiscal 2025 results on August

P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable

Celcuity (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for cancer, released its second quarter 2025 earnings on August 14, 2025. The highlight was topline Phase

Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than

Daré Bioscience (NASDAQ:DARE), a women’s health-focused biopharmaceutical company developing new therapies and devices, announced its second quarter 2025 results on August 14, 2025. The headline

Shares of department store company Dillard's (NYSE: DDS) rallied on Thursday, up 5.4% as of 2 p.m. ET.

Dillard's reported second-quarter earnings that, while certainly not eye-opening from a growth